What does PHARMACIE CLABOTS do?

PHARMACIE CLABOTS is a logistics company in Genappe. Private Limited, started on 23 December 1993, 1 establishment.

What is the address of PHARMACIE CLABOTS?

The registered office of PHARMACIE CLABOTS is located at Rue de Villers-la-Ville 78, 1470 Genappe.

Is PHARMACIE CLABOTS still active?

Yes. According to the CBE (30 October 2026) PHARMACIE CLABOTS is active, legal situation “Normale toestand”, started on 23 December 1993.

Is PHARMACIE CLABOTS registered on Peppol?

Yes, PHARMACIE CLABOTS is registered on the Peppol network with ID 0208:0451595376.

What is the enterprise number of PHARMACIE CLABOTS?

The enterprise number of PHARMACIE CLABOTS is BE0451595376.

When was PHARMACIE CLABOTS founded?

PHARMACIE CLABOTS was founded on 23 December 1993.

Who are the directors of PHARMACIE CLABOTS?

According to the 2025 annual accounts, the directors of PHARMACIE CLABOTS are: C.V.H. SPRL, Marie DE VRIESE.

Is PHARMACIE CLABOTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 1993; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE CLABOTS make in 2025?

PHARMACIE CLABOTS recorded a loss after taxes of € 61,504 in financial year 2025.

What is the revenue of PHARMACIE CLABOTS?

As a small company, PHARMACIE CLABOTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 712,343.

How much does an employee at PHARMACIE CLABOTS earn?

The average wage cost per full-time employee at PHARMACIE CLABOTS was € 69,900 in 2025: staff costs of € 384,606 for 5.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE CLABOTS have?

According to the 2025 annual accounts, PHARMACIE CLABOTS has 5.5 full-time equivalents (FTE).

PHARMACIE CLABOTS (Private Limited) - Genappe

Dossier PHARMACIE CLABOTS, printed on 30 October 2026 from databakkes.be/en/0451595376/pharmacie-clabots. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 55 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE CLABOTS from Genappe, company number BE0451595376, closed financial year 2025 with a result of € -61,504 after tax. For that financial year PHARMACIE CLABOTS recorded a gross margin of € 712,343 and equity of € 433,074. Compared with financial year 2024, the result moved from € 30,486 to € -61,504. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Healthy

€ 433,074

▼ 12% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -61,504

▼ still € 30,486 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,746

▼ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 414,474.

People and assets in 2025

Full-time equivalents

5.5

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 384,606

▼ 9% vs 2024

€ 69,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 35,616

▼ 49% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 939,138

▼ 20% vs 2024

€ 189,713 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 97,149

▲ 53% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 55,064

▼ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 811,795 Gross margin 2022: € 811,795 First fiscal year in the series	€ 612,635 Gross margin 2023: € 612,635 ▼ 25% vs 2022 (€ 811,795) Unfavourable step	€ 636,649 Gross margin 2024: € 636,649 ▲ 4% vs 2023 (€ 612,635) Favourable step	€ 712,343 Gross margin 2025: € 712,343 ▲ 12% vs 2024 (€ 636,649) Favourable step	▲ 12%
Profit after taxes	€ 383,172 Profit after taxes 2022: € 383,172 First fiscal year in the series	€ 191,878 Profit after taxes 2023: € 191,878 ▼ 50% vs 2022 (€ 383,172) Unfavourable step	€ 30,486 Profit after taxes 2024: € 30,486 ▼ 84% vs 2023 (€ 191,878) Unfavourable step	€ -61,504 Profit after taxes 2025: € -61,504 ▼ € 91,990 vs 2024 (€ 30,486) Unfavourable step	▼ € 91,990
Equity	€ 462,214 Equity 2022: € 462,214 First fiscal year in the series	€ 554,092 Equity 2023: € 554,092 ▲ 20% vs 2022 (€ 462,214) Favourable step	€ 494,578 Equity 2024: € 494,578 ▼ 11% vs 2023 (€ 554,092) Unfavourable step	€ 433,074 Equity 2025: € 433,074 ▼ 12% vs 2024 (€ 494,578) Unfavourable step	▼ 12%
Total debts	€ 1,424,940 Total debts 2022: € 1,424,940 First fiscal year in the series	€ 1,860,058 Total debts 2023: € 1,860,058 ▲ 31% vs 2022 (€ 1,424,940) Unfavourable step	€ 1,596,092 Total debts 2024: € 1,596,092 ▼ 14% vs 2023 (€ 1,860,058) Favourable step	€ 1,359,373 Total debts 2025: € 1,359,373 ▼ 15% vs 2024 (€ 1,596,092) Favourable step	▼ 15%
Cash	€ 130,813 Cash 2022: € 130,813 First fiscal year in the series	€ 140,386 Cash 2023: € 140,386 ▲ 7% vs 2022 (€ 130,813) Favourable step	€ 188,498 Cash 2024: € 188,498 ▲ 34% vs 2023 (€ 140,386) Favourable step	€ 142,746 Cash 2025: € 142,746 ▼ 24% vs 2024 (€ 188,498) Unfavourable step	▼ 24%
Retained profit	€ 443,614 Retained profit 2022: € 443,614 First fiscal year in the series	€ 535,492 Retained profit 2023: € 535,492 ▲ 21% vs 2022 (€ 443,614) Favourable step	€ 475,978 Retained profit 2024: € 475,978 ▼ 11% vs 2023 (€ 535,492) Unfavourable step	€ 414,474 Retained profit 2025: € 414,474 ▼ 13% vs 2024 (€ 475,978) Unfavourable step	▼ 13%
Dividend	€ 120,000 Dividend 2022: € 120,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▼ 17% vs 2022 (€ 120,000) Unchanged	€ 90,000 Dividend 2024: € 90,000 ▼ 10% vs 2023 (€ 100,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 90,000) Unchanged	▼ 100%
Bank debt	€ 918,698 Bank debt 2022: € 918,698 First fiscal year in the series	€ 1,323,821 Bank debt 2023: € 1,323,821 ▲ 44% vs 2022 (€ 918,698) Unfavourable step	€ 1,168,190 Bank debt 2024: € 1,168,190 ▼ 12% vs 2023 (€ 1,323,821) Favourable step	€ 939,138 Bank debt 2025: € 939,138 ▼ 20% vs 2024 (€ 1,168,190) Favourable step	▼ 20%
Balance sheet total	€ 1,887,154 Balance sheet total 2022: € 1,887,154 First fiscal year in the series	€ 2,414,150 Balance sheet total 2023: € 2,414,150 ▲ 28% vs 2022 (€ 1,887,154) Unchanged	€ 2,090,670 Balance sheet total 2024: € 2,090,670 ▼ 13% vs 2023 (€ 2,414,150) Unchanged	€ 1,792,446 Balance sheet total 2025: € 1,792,446 ▼ 14% vs 2024 (€ 2,090,670) Unchanged	▼ 14%
Employees (FTE)	3.1 Employees (FTE) 2022: 3.1 First fiscal year in the series	5.9 Employees (FTE) 2023: 5.9 ▲ 2.8 vs 2022 (3.1) Unchanged	5.9 Employees (FTE) 2024: 5.9 Unchanged (5.9) Unchanged	5.5 Employees (FTE) 2025: 5.5 ▼ 0.4 vs 2024 (5.9) Unchanged	▼ 0.4

Key figures of PHARMACIE CLABOTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE CLABOTS?

What happened at PHARMACIE CLABOTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: loss of € 61,504 (▼ € 91,990 vs 2024). Source: NBB ↗
Jan 12, 1994 New establishment in Genappe. KBO
Dec 23, 1993 Start of the company according to the CBE. KBO

In short

From € 383,172 profit in 2022 to € 61,504 loss in 2025.

Paid € 250,101 in corporate taxes since 2022.

Best year ever: 2022, with € 383,172 profit.

On average € 129,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

C.V.H. 100%

The stake of C.V.H. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE CLABOTS

Behind PHARMACIE CLABOTS are C.V.H. SPRL and Marie DE VRIESE. The shares are held by C.V.H. (100%).

Directors

According to the 2025 annual accounts

C.V.H. SPRL

Manager · represented by Pierre CLABOTS

Marie DE VRIESE

Director

Also active at: C.V.H., MDV Pharma, PIMAC, GENAPPE PHARMA INVEST

Shareholders

C.V.H.

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Villers-la-Ville 78

1470 Genappe

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

C.V.H. same network

€ 562,845 gross margin · 2025

UTVA HOLDING PHARMA

MDV Pharma same network

€ 24,169 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0451.595.376

VAT number

BE 0451.595.376

Registered office

Rue de Villers-la-Ville 78, 1470 Genappe

Names & denominations

PHARMACIE CLABOTS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 December 1993

Peppol

Active · Active since 22 May 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE CLABOTS

Warning lights

Financials

What happened to PHARMACIE CLABOTS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions